Enanta Pharmaceuticals
Presence
Enanta Pharmaceuticals is one of the...
Enanta Pharmaceuticals is a company listed under the stock ticker ENTA (US).
Executives
View the org chart displaying its 12 main executives
Most searched biographies at Enanta Pharmaceuticals
- Jay Luly, President, Chief Executive Officer and Director
- Kristine Peterson, Director
- Terry Vance, Director
Popular executive movements at Enanta Pharmaceuticals
- Nathaniel Gardiner, Senior Vice President and General Counsel, will retire on Mar. 30, 2024 (posted on December 27 2023).
Create your alert
to follow the executive moves at Enanta Pharmaceuticals.
Pharmaceuticals
Enanta Pharmaceuticals has 1,868 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Enanta Pharmaceuticals
- Enanta Pharmaceuticals to Host Conference Call on August 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30, 2022 | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Announces Positive Data from a Phase 1 Clinical Study of EDP-235, its Oral 3CL Protease Inhibitor Designed for the Treatment of COVID-19 | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022 | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals to Participate in Two Investor Conferences in June | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Reports Topline Data from the RSVP Study of EDP-938 in Otherwise Healthy Adults with Community-Acquired Respiratory Syncytial Virus (RSV) | Enanta Pharmaceuticals, Inc.
- Press Releases | Enanta Pharmaceuticals, Inc.
- Press Releases | Enanta Pharmaceuticals, Inc.
- Press Releases | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2022 With Webcast and Conference Call Today at 4:30 p.m. ET | Enanta Pharmaceuticals, Inc.
- View more press releases Close
Social media about Enanta Pharmaceuticals
- Enanta Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Enanta Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jay Luly 
Call Enanta Pharmaceuticals at +1 617...
